Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127371161 | 12737116 | 1 | I | 20050817 | 20050908 | 20160913 | 20160913 | EXP | W814561 | GB-OTSUKA-02100-EUR-05-0001 | OTSUKA | 75.00 | YR | M | Y | 0.00000 | 20160913 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127371161 | 12737116 | 1 | PS | PLETAL | CILOSTAZOL | 1 | Oral | 100 MG, QD | 2600 | MG | Y | 20863 | 100 | MG | TABLET | QD | |||
| 127371161 | 12737116 | 2 | SS | PLETAL | CILOSTAZOL | 1 | 2600 | MG | Y | 20863 | TABLET | ||||||||
| 127371161 | 12737116 | 3 | C | GTN | NITROGLYCERIN | 1 | Unknown | 1 DF (PUFF), PRN | 0 | 1 | DF | ||||||||
| 127371161 | 12737116 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, TID | 0 | 500 | MG | TID | |||||||
| 127371161 | 12737116 | 5 | C | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | Unknown | 60 MG, QD | 0 | 60 | MG | QD | |||||||
| 127371161 | 12737116 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 80 MG, QD | 0 | 80 | MG | QD | |||||||
| 127371161 | 12737116 | 7 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 50 MG, QD | 0 | 50 | MG | QD | |||||||
| 127371161 | 12737116 | 8 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 127371161 | 12737116 | 9 | C | ENOXAPARIN | ENOXAPARIN | 1 | Subcutaneous | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 127371161 | 12737116 | 10 | C | CAPTOPRIL. | CAPTOPRIL | 1 | Unknown | 25 MG, TID | 0 | 25 | MG | TID | |||||||
| 127371161 | 12737116 | 11 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 150 MG, QD | 0 | 150 | MG | QD | |||||||
| 127371161 | 12737116 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 127371161 | 12737116 | 13 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 1 MG, QD | 0 | 1 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127371161 | 12737116 | 1 | Intermittent claudication |
| 127371161 | 12737116 | 2 | Peripheral artery occlusion |
| 127371161 | 12737116 | 3 | Product used for unknown indication |
| 127371161 | 12737116 | 4 | Product used for unknown indication |
| 127371161 | 12737116 | 5 | Product used for unknown indication |
| 127371161 | 12737116 | 6 | Product used for unknown indication |
| 127371161 | 12737116 | 7 | Product used for unknown indication |
| 127371161 | 12737116 | 8 | Product used for unknown indication |
| 127371161 | 12737116 | 9 | Thrombosis prophylaxis |
| 127371161 | 12737116 | 10 | Hypertension |
| 127371161 | 12737116 | 11 | Prophylaxis |
| 127371161 | 12737116 | 12 | Blood cholesterol increased |
| 127371161 | 12737116 | 13 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127371161 | 12737116 | HO |
| 127371161 | 12737116 | LT |
| 127371161 | 12737116 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127371161 | 12737116 | Chest pain | |
| 127371161 | 12737116 | Myocardial infarction | |
| 127371161 | 12737116 | Pulmonary hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127371161 | 12737116 | 1 | 20050723 | 20050819 | 0 | |
| 127371161 | 12737116 | 9 | 20050815 | 20050819 | 0 |